No. 23A530

Hope Medical Enterprises, Inc. v. Fagron Compounding Services, LLC, et al.

Lower Court: Ninth Circuit
Docketed: 2023-12-12
Status: Presumed Complete
Type: A
Experienced Counsel
Tags: drug-approval enforcement fdca preemption private-litigation state-law
Latest Conference: N/A
Question Presented (from Petition)

Question not identified.

Question Presented (AI Summary)

Whether the Food, Drug, and Cosmetic Act's enforcement provision preempts state-law claims that mirror federal drug approval requirements

Docket Entries

2023-12-17
Application (23A530) granted by Justice Kagan extending the time to file until January 16, 2024.
2023-12-07
Application (23A530) to extend the time to file a petition for a writ of certiorari from December 31, 2023 to January 16, 2024, submitted to Justice Kagan.
Main DocumentLower Court Orders/OpinionsProof of ServiceMain DocumentLower Court Orders/OpinionsProof of Service

Attorneys

Hope Medical Enterprises, Inc.
Jeffrey S. Bucholtz — King & Spalding LLP, Petitioner